BAY2599023 (DTX201) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-15 in 3mo
ESTIMATED |
READOUT
Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond
Phase 1/2 · Hemophilia A |
Bayer | BAY2599023 (DTX201) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|